QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
OVERVIEW - QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
Quintiles Phase One Clinical Trials India Private Limited is an unlisted private company incorporated on 03 July, 2009. It is classified as a private subsidiary of a foreign company and is located in , Telangana. It's authorized share capital is INR 38.00 cr and the total paid-up capital is INR 36.57 cr.
The current status of Quintiles Phase One Clinical Trials India Private Limited is - Dissolved.
The last reported AGM (Annual General Meeting) of Quintiles Phase One Clinical Trials India Private Limited, per our records, was held on 29 June, 2020.
Quintiles Phase One Clinical Trials India Private Limited has three directors - Kovelamudi Hari Prasad, Arjun Aiyar, and others.
The Corporate Identification Number (CIN) of Quintiles Phase One Clinical Trials India Private Limited is U73100TG2009FTC064239. The registered office of Quintiles Phase One Clinical Trials India Private Limited is at 7TH & 8TH FLOOR, APOLLO HEALTH STREET BUILDING, APOLLO HEALTH CITY, BEHIND KBR PARK, JUB ILEE HILLS NA HYDERABAD Kurnool , Telangana.
One, the company is not active and operating under this name (please check status mentioned below the company name). This could be because it was closed, merged, struck off or is in the process of closing.
Second, it was very recently formed (please check incorporation date) and financial information is not available yet.
You could, however, see its basic information and its directors by scrolling down.
Company360 plans
Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
REGISTERED DETAILS - QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
CIN
U73100TG2009FTC064239
Incorporation Date / Age
03 July, 2009 / 15 yrs
Last Reported AGM Date
29 June, 2020
Authorized Capital
INR 3800.0 Lacs
Paidup Capital
INR 3657.12 Lacs
industry*
Research and Development
type
Unlisted Private Company
category
Company limited by Shares
subcategory
Subsidiary of Foreign Company
Registered Address
7TH & 8TH FLOOR, APOLLO HEALTH STREET BUILDING, APOLLO HEALTH CITY, BEHIND KBR PARK, JUB ILEE HILLS NA HYDERABAD Kurnool
Telangana - 500033
India
How to download QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED report
A Company report by Tofler is an easy-to-read PDF report that includes company's financial information, ratio analysis, management, group structure, shareholding pattern and more. Such reports can be bought from company pages at Tofler (Sample) or can be downloaded from Company360. Here is the video showing how a report downloaded from Company360 looks like.
QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED - Registration Details | ||||||
---|---|---|---|---|---|---|
CIN | U73100TG2009FTC064239 | |||||
Incorporation Date / Age | 03 July, 2009 / 15 yrs | |||||
Last Reported AGM Date | 29 June, 2020 | |||||
Authorized Capital | INR 3800.0 Lacs | |||||
Paidup Capital | INR 3657.12 Lacs | |||||
industry* | Research and Development | |||||
type | Unlisted Private Company | |||||
category | Company limited by Shares | |||||
subcategory | Subsidiary of Foreign Company | |||||
Email Address | ||||||
Website | ||||||
Registered Address | 7TH & 8TH FLOOR, APOLLO HEALTH STREET BUILDING, APOLLO HEALTH CITY, BEHIND KBR PARK, JUB ILEE HILLS NA HYDERABAD Kurnool Telangana - 500033 India |
Directors - QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
The company has 3 directors and 1 reported key management personnel.
The longest serving director currently on board is Kovelamudi Hari Prasad who was appointed on 15 May, 2013. Kovelamudi Hari Prasad has been on the board for more than 11 years. The most recently appointed director is Nilanjan Sinha, who was appointed on 14 November, 2016.
Nilanjan Sinha has the largest number of other directorships with a seat at a total of 10 companies. In total, the company is connected to 16 other companies through its directors.
NAME | DESIGNATION | APPOINTMENT DATE | |
---|---|---|---|
KOVELAMUDI HARI PRASAD | Director | 15 May, 2013 | Other directorships - SOBHAGYA HOSPITAL AND RESEARCH CENTRE PRIVATE LIMITED, SAMUDRA HEALTH CARE ENTERPRISES LIMITED, APOLLO SHINE FOUNDATION, KURNOOL HOSPITAL ENTERPRISES LIMITED, HSRL ENTERPRISES PRIVATE LIMITED, APOKOS REHAB PRIVATE LIMITED, QUALITY CARE INDIA LIMITED, |
ARJUN AIYAR | Director | 01 November, 2016 | Other directorships - CLINTEC CRO SERVICES (INDIA) PRIVATE LIMITED, 159 TECHNOLOGY SOLUTIONS PRIVATE LIMITED, EXCEL LIFE SCIENCES PRIVATE LIMITED, CENDUIT (INDIA) SERVICES PRIVATE LIMITED, Q SQUARED SOLUTIONS (INDIA) PRIVATE LIMITED, IQVIA ANALYTICS SERVICES PRIVATE LIMITED, IQVIA RDS (INDIA) PRIVATE LIMITED, |
NILANJAN SINHA | Director | 14 November, 2016 | Other directorships - AECIO IT SOLUTIONS INDIA PRIVATE LIMITED, CLINTEC CRO SERVICES (INDIA) PRIVATE LIMITED, 159 TECHNOLOGY SOLUTIONS PRIVATE LIMITED, EXCEL LIFE SCIENCES PRIVATE LIMITED, CENDUIT (INDIA) SERVICES PRIVATE LIMITED, Q SQUARED SOLUTIONS (INDIA) PRIVATE LIMITED, IMS HEALTH TECHNOLOGY SOLUTIONS INDIA PRIVATE LIMITED, IQVIA ANALYTICS SERVICES PRIVATE LIMITED, IQVIA RDS (INDIA) PRIVATE LIMITED, |
KHUSBOO SINGHVI | KMP | 24 April, 2019 | No other directorships |
NAME | DESIGNATION | APPOINTMENT DATE | |||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
KOVELAMUDI HARI PRASAD | Director | 15 May, 2013 | View other directorships | ||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
ARJUN AIYAR | Director | 01 November, 2016 | View other directorships | ||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
NILANJAN SINHA | Director | 14 November, 2016 | View other directorships | ||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||
KHUSBOO SINGHVI | KMP | 24 April, 2019 | No other directorships | ||||||||||||||||||||||||||||||||||||||||||||||||
|
Director
Director
Director
KHUSBOO SINGHVI
KMP
Previous Names
No previous names were found for this company. |
Previous CINs
No previous CINs were found for this company. |
SIMILAR COMPANIES
NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL | |
---|---|---|---|---|
OAT & IIL INDIA LABORATORIES PRIVATE LIMITED
It was formed in year 2013 in Delhi . The company currently has a paid up capital of INR 39.75 cr.
|
2013 | Delhi | 39.75 cr | Buy financial reports |
BELOORBAYIR BIOTECH LIMITED
It was formed in year 2005 in Karnataka . The company currently has a paid up capital of INR 39.94 cr.
|
2005 | Karnataka | 39.94 cr | Buy financial reports |
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED
It was formed in year 2006 in Gujarat . The company currently has a paid up capital of INR 32.45 cr.
|
2006 | Gujarat | 32.45 cr | Buy financial reports |
RUCHI HI-RICH SEEDS PRIVATE LIMITED
It was formed in year 2014 in Maharashtra . The company currently has a paid up capital of INR 40.81 cr.
|
2014 | Maharashtra | 40.81 cr | Buy financial reports |
RESEARCH TRIANGLE INSTITUTE GLOBAL INDIA PRIVATE LIMITED
It was formed in year 2014 in Delhi . The company currently has a paid up capital of INR 41.42 cr.
|
2014 | Delhi | 41.42 cr | Buy financial reports |
FARCAST BIOSCIENCES INDIA PRIVATE LIMITED
It was formed in year 2016 in Karnataka . The company currently has a paid up capital of INR 31.00 cr.
|
2016 | Karnataka | 31.00 cr | Buy financial reports |
PATANJALI ORGANIC RESEARCH INSTITUTE PRIVATE LIMITED
It was formed in year 2011 in Uttarakhand . The company currently has a paid up capital of INR 30.61 cr.
|
2011 | Uttarakhand | 30.61 cr | Buy financial reports |
ECRON ACUNOVA LIMITED
It was formed in year 2004 in Karnataka . The company currently has a paid up capital of INR 42.98 cr.
|
2004 | Karnataka | 42.98 cr | Buy financial reports |
JAYABHERI AUTOMOTIVES PRIVATE LIMITED
It was formed in year 2011 in Tamil Nadu . The company currently has a paid up capital of INR 30.00 cr.
|
2011 | Tamil Nadu | 30.00 cr | Buy financial reports |
HAMON RESEARCH COTTRELL INDIA PRIVATE LIMITED
It was formed in year 2011 in Tamil Nadu . The company currently has a paid up capital of INR 29.39 cr.
|
2011 | Tamil Nadu | 29.39 cr | Buy financial reports |
NAME | INCORPORATION YEAR | STATE | PAID UP CAPITAL |
---|---|---|---|
OAT & IIL INDIA LABORATORIES PRIVATE LIMITED | 2013 | Delhi | 39.75 cr |
BELOORBAYIR BIOTECH LIMITED | 2005 | Karnataka | 39.94 cr |
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED | 2006 | Gujarat | 32.45 cr |
RUCHI HI-RICH SEEDS PRIVATE LIMITED | 2014 | Maharashtra | 40.81 cr |
RESEARCH TRIANGLE INSTITUTE GLOBAL INDIA PRIVATE LIMITED | 2014 | Delhi | 41.42 cr |
FARCAST BIOSCIENCES INDIA PRIVATE LIMITED | 2016 | Karnataka | 31.00 cr |
PATANJALI ORGANIC RESEARCH INSTITUTE PRIVATE LIMITED | 2011 | Uttarakhand | 30.61 cr |
ECRON ACUNOVA LIMITED | 2004 | Karnataka | 42.98 cr |
JAYABHERI AUTOMOTIVES PRIVATE LIMITED | 2011 | Tamil Nadu | 30.00 cr |
HAMON RESEARCH COTTRELL INDIA PRIVATE LIMITED | 2011 | Tamil Nadu | 29.39 cr |
SUBSIDIARY COMPANIES
No Indian subsidiary companies found.
Company Network - QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
How to use company network of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
Tofler Company network is a powerful feature that allows you to explore and discover common directorships between companies. It helps you find out other directorships of an Indian director and where else he has business interests. The feature is available for unlimited use in Company360 platform. Here is the video showing how you can explore company networks to discover hidden relationships between companies.
FAQ - QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED
-
What is the Incorporation date of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED?
The Incorporation Date of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED is 03 July, 2009.
-
What is authorized share capital of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED?
The authorized share capital of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED is INR 3800.0 Lacs.
-
What is the paid-up capital of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED?
The paid up capital of the QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED is INR 3657.12 Lacs.
-
What is the registered address of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED?
The registered address of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED is 7TH & 8TH FLOOR, APOLLO HEALTH STREET BUILDING, APOLLO HEALTH CITY, BEHIND KBR PARK, JUB ILEE HILLS NA HYDERABAD Kurnool
Telangana - 500033
India. -
What is the CIN number of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED?
The CIN number of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED is U73100TG2009FTC064239.
-
Who are the directors of QUINTILES PHASE ONE CLINICAL TRIALS INDIA PRIVATE LIMITED?
Quintiles Phase One Clinical Trials India Private Limited has three directors - Kovelamudi Hari Prasad, Arjun Aiyar, and others.
One, the company is not active and operating under this name (please check status mentioned below the company name). This could be because it was closed, merged, struck off or is in the process of closing.
Second, it was very recently formed (please check incorporation date) and financial information is not available yet.
You could, however, see its basic information and its directors by scrolling down.
Company360 plans
Know more about your vendors, clients and competitors.
Financials, scores, ratios, excels, reports and more.
@ INR 9000/quarter
Join our newsletter
Tofler, TWS Systems Private Limited and its officers respect the Intellectual Property Rights of all people. Tofler makes no claim of ownership or affiliation with any trademark (REGISTERED OR UNREGISTERED) that forms part of any Company/LLP name listed on this page. Trademarks, if any, listed on this page belong to their respective owners. Read More